Task: Answer the multiple-choice question.
Question: Which drug exhibits a 1.615% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) COC(=O)[C@H](CC(C)C)NC(=O)NCCC1=CCCCC1
b.) O=C(COC(=O)/C=C/c1ccccc1)NCc1ccccc1Cl
c.) O=C(COC(=O)c1cccnc1Cl)c1ccc(Cl)cc1Cl
d.) Fc1ccccc1/C=N/Nc1ncnc2ccccc12
Answer: a. COC(=O)[C@H](CC(C)C)NC(=O)NCCC1=CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)[C@H](CC(C)C)NC(=O)NCCC1=CCCCC1
COC(=O)[C@H](CC(C)C)NC(=O)NCCC1=CCCCC1
methyl (2S)-2-[2-(cyclohexen-1-yl)ethylcarbamoylamino]-4-methylpentanoate